Cagrilintide
Cagrilintide (AM833, NNC0174-0833)
Long-acting synthetic amylin analogue for weight management and type 2 diabetes. Works as a dual amylin and calcitonin receptor agonist (DACRA), mimicking natural amylin hormone to regulate appetite, slow gastric emptying, and promote satiety.
Complete Dosing Guide
Administration Guidelines
Injection Sites
- Abdomen (2 inches from navel)
- Front of thighs
- Back of upper arms
Rotation Schedule
- Use a different area each week
- Keep a rotation log
- Avoid areas with scars, bruises, or irritation
Timing
- Same day each week, with or without food
- Peak concentration: 24 hours after injection
- Half-life: ~184 hours (7.7 days)
Administration Guidelines
Injection Sites
Subcutaneous injection sites include:
- Abdomen (2 inches from navel)
- Front of thighs
- Back of upper arms
Rotation Schedule
- Use a different area each week
- Keep a rotation log
- Avoid areas with scars, bruises, or irritation
Timing
- Once-weekly subcutaneous injection
- Same day each week, with or without food
- Rotate injection sites (abdomen, thigh, upper arm)
Medical Disclaimer
Clinical data presented is from peer-reviewed studies. Individual results may vary. Consult healthcare professionals before starting treatment. This information is for educational purposes only.